This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2019
Title: Paola Sinibaldi-Vallebona: Innovator in Cancer Detection
Introduction
Paola Sinibaldi-Vallebona is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of cancer detection through her innovative research and development of monoclonal antibodies. Her work focuses on early detection methods that can potentially improve patient outcomes in oncology.
Latest Patents
Paola holds a patent for a monoclonal antibody to the human line-1 ORF2 protein. The patent is titled "Monoclonal antibody to human line-1 ORF2 protein and method for early detection of transforming cells in pre-neoplastic tissues of a human subject." This invention relates to a monoclonal antibody that specifically binds to the human Long Interspersed Element-1 ORF2 encoded protein (L1-ORF2p). The antibody is obtained from hybridoma chA1 and has various applications, including predicting the response of cancer patients to NNRTI treatments. Additionally, the patent outlines a method for early detection of cell transformation in pre-neoplastic tissues by detecting L1-ORF2p expression, which indicates the presence of cell transformation. It also includes a method for monitoring the progression of colon adenoma based on L1-ORF2p expression levels.
Career Highlights
Throughout her career, Paola has demonstrated a commitment to advancing medical research and improving cancer detection methodologies. Her innovative approach has garnered attention in the scientific community, and her patent reflects her dedication to addressing critical health challenges.
Collaborations
Paola has collaborated with notable colleagues, including Corrado Spadafora and Ilaria Sciamanna. These partnerships have contributed to her research and the development of her patented technologies.
Conclusion
Paola Sinibaldi-Vallebona is a trailblazer in the field of cancer detection, with her patented monoclonal antibody offering promising advancements in early diagnosis and treatment response prediction. Her work exemplifies the impact of innovation in healthcare and the importance of continued research in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile